Predictably, Solazyme has filed for an initial public offering (IPO), targeting $100 million. Why was it predictable? Because just as Amyris bolstered its business with multiple strong partnerships in the months leading up to its IPO (see the July 6, 2010 LRBJ), Solazyme has been tying up with some ...
This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!
News Commentary | May 13, 2021
With an estimated transaction value of $100 million, Ingredion will get exclusive license to sell and market Amyris' Reb M sweetener technology under this agreement. Additionally, Ingredion will also get a minority stake in Amyris' new production facility in Brazil, to be completed by Q4 2021. ... Not part of subscription
News Commentary | July 08, 2021
The Bio‑Based Industries Joint Undertaking (BBI JU) has granted €15 million in funding to French company Microphyt (Lux Take: Engage) through the SCALE project. This four‑year project, spearheaded by Microphyt, will bring together 11 industrial partners and enable the construction of a microalgae ... Not part of subscription
News Commentary | July 14, 2021
Operating as Clariant IGL Specialty Chemicals, the JV combines India Glycols' renewable bio‑EO derivatives business with Clariant's Industrial & Consumer Specialties business in India, Sri Lanka, Bangladesh, and Nepal. This partnership isn't too surprising given the rise in demand for "eco‑... Not part of subscription